288 related articles for article (PubMed ID: 17630817)
1. Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation.
Halbreich U
CNS Drugs; 2007; 21(8):641-57. PubMed ID: 17630817
[TBL] [Abstract][Full Text] [Related]
2. [Osteoporosis risk factors among patients with schizophrenia].
Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
Przegl Lek; 2006; 63(3):134-8. PubMed ID: 16969898
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
O'Keane V
J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in male schizophrenia patients: a review.
Meyer JM; Lehman D
Ann Clin Psychiatry; 2006; 18(1):43-8. PubMed ID: 16517452
[TBL] [Abstract][Full Text] [Related]
5. [Decrease in mineral bone density in schizophrenic patients treated with 2nd generation antipsychotics].
Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
Psychiatr Pol; 2005; 39(6):1173-84. PubMed ID: 16526183
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density.
Stubbs B
J Psychiatr Ment Health Nurs; 2009 Nov; 16(9):838-42. PubMed ID: 19824978
[TBL] [Abstract][Full Text] [Related]
7. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.
De Hert M; Detraux J; Stubbs B
Expert Opin Drug Saf; 2016 Jun; 15(6):809-23. PubMed ID: 26986209
[TBL] [Abstract][Full Text] [Related]
8. Schizophrenia and osteoporosis.
Lean M; De Smedt G
Int Clin Psychopharmacol; 2004 Jan; 19(1):31-5. PubMed ID: 15101568
[TBL] [Abstract][Full Text] [Related]
9. Osteoporosis and fracture risk in people with schizophrenia.
Kishimoto T; De Hert M; Carlson HE; Manu P; Correll CU
Curr Opin Psychiatry; 2012 Sep; 25(5):415-29. PubMed ID: 22744405
[TBL] [Abstract][Full Text] [Related]
10. Reduced bone mineral density in patients with schizophrenia receiving prolactin raising anti-psychotic medication.
Meaney AM; O'Keane V
J Psychopharmacol; 2003 Dec; 17(4):455-8. PubMed ID: 14870961
[TBL] [Abstract][Full Text] [Related]
11. Bone Mineral Density in Schizophrenia: An Update of Current Meta-Analysis and Literature Review Under Guideline of PRISMA.
Tseng PT; Chen YW; Yeh PY; Tu KY; Cheng YS; Wu CK
Medicine (Baltimore); 2015 Nov; 94(47):e1967. PubMed ID: 26632691
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density changes over a year in young females with schizophrenia: relationship to medication and endocrine variables.
Meaney AM; O'Keane V
Schizophr Res; 2007 Jul; 93(1-3):136-43. PubMed ID: 17467954
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis in patients with schizophrenia.
Hummer M; Malik P; Gasser RW; Hofer A; Kemmler G; Moncayo Naveda RC; Rettenbacher MA; Fleischhacker WW
Am J Psychiatry; 2005 Jan; 162(1):162-7. PubMed ID: 15625215
[TBL] [Abstract][Full Text] [Related]
14. Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes.
Halbreich U; Palter S
Schizophr Bull; 1996; 22(3):447-54. PubMed ID: 8873295
[TBL] [Abstract][Full Text] [Related]
15. [Hyperprolactinaemia and bone mineral density].
Kostrzak A; Męczekalski B
Pol Merkur Lekarski; 2015 Aug; 39(230):122-5. PubMed ID: 26319389
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for osteoporosis in chronic schizophrenia on long-term treatment with antipsychotics: a cross-sectional study.
Liu F; Wu Y; Chen J; Zou T; Qin Y; Teng Z; Su Y; Wu R; Huang J
BMC Psychiatry; 2023 Jun; 23(1):454. PubMed ID: 37344770
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents.
Naidoo U; Goff DC; Klibanski A
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():97-108. PubMed ID: 12650684
[TBL] [Abstract][Full Text] [Related]
18. Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
Hummer M; Huber J
Curr Med Res Opin; 2004; 20(2):189-97. PubMed ID: 15006013
[TBL] [Abstract][Full Text] [Related]
19. Risk of osteoporosis and fracture incidence in patients on antipsychotic medication.
Graham SM; Howgate D; Anderson W; Howes C; Heliotis M; Mantalaris A; Tsiridis E; Tsapakis E
Expert Opin Drug Saf; 2011 Jul; 10(4):575-602. PubMed ID: 21385106
[TBL] [Abstract][Full Text] [Related]
20. Lower Bone Mineral Density at the Hip and Lumbar Spine in People with Psychosis Versus Controls: a Comprehensive Review and Skeletal Site-Specific Meta-analysis.
Gomez L; Stubbs B; Shirazi A; Vancampfort D; Gaughran F; Lally J
Curr Osteoporos Rep; 2016 Dec; 14(6):249-259. PubMed ID: 27696144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]